Submitted:
08 April 2025
Posted:
09 April 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Methods
Study Population
Hair Sample Collection and Analysis
Statistical Analysis
3. Results
4. Discussion
Reference Upper Limit Determination and Toxicological Relevance
Comparison with Previous Studies
5. Potential Limitations
6. Conclusions
Supplementary Materials
Author Contributions
Acknowledgments
References
- Brown, R.H.; Al-Chalabi, A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017, 377, 162–172. [Google Scholar] [CrossRef] [PubMed]
- van Es, M.A.; Hardiman, O.; Chio, A.; Al-Chalabi, A.; Pasterkamp, R.J.; Veldink, J.H.; van den Berg, L.H. Amyotrophic Lateral Sclerosis. Lancet 2017, 390, 2084–2098. [Google Scholar] [CrossRef]
- Kiernan, M.C.; Vucic, S.; Cheah, B.C.; Turner, M.R.; Eisen, A.; Hardiman, O.; Burrell, J.R.; Zoing, M.C. Amyotrophic Lateral Sclerosis. Lancet 2011, 377, 942–955. [Google Scholar] [CrossRef] [PubMed]
- Carter, G.T.; Miller, R.G. Comprehensive Management of Amyotrophic Lateral Sclerosis. Phys. Med. Rehabil. Clin. N. Am. 1998, 9, 271–284. [Google Scholar] [CrossRef] [PubMed]
- Chiò, A.; Logroscino, G.; Traynor, B.J.; Collins, J.; Simeone, J.C.; Goldstein, L.A.; White, L.A. Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature. Neuroepidemiology 2013, 41, 118–130. [Google Scholar] [CrossRef]
- Goutman, S.A.; Hardiman, O.; Al-Chalabi, A.; Chió, A.; Savelieff, M.G.; Kiernan, M.C.; Feldman, E.L. Recent Advances in the Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis. Lancet Neurol. 2022, 21, 480–493. [Google Scholar] [CrossRef]
- Blasco, H.; Mavel, S.; Corcia, P.; Gordon, P.H. The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development. Curr. Med. Chem. 2014, 21, 3551–3575. [Google Scholar] [CrossRef]
- Boillée, S.; Vande Velde, C.; Cleveland, D.W.W. ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors. Neuron 2006, 52, 39–59. [Google Scholar] [CrossRef]
- Ferraiuolo, L.; Higginbottom, A.; Heath, P.R.; Barber, S.; Greenald, D.; Kirby, J.; Shaw, P.J. Dysregulation of Astrocyte-Motoneuron Cross-Talk in Mutant Superoxide Dismutase 1-Related Amyotrophic Lateral Sclerosis. Brain 2011, 134, 2627–2641. [Google Scholar] [CrossRef]
- Renton, A.E.; Chiò, A.; Traynor, B.J. State of Play in Amyotrophic Lateral Sclerosis Genetics. Nat. Neurosci. 2014, 17, 17–23. [Google Scholar] [CrossRef]
- Ghasemi, M.; Brown, R.H. Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harb. Perspect. Med. 2018, 8. [Google Scholar] [CrossRef] [PubMed]
- Van Damme, P.; Robberecht, W.; Van Den Bosch, L. Modelling Amyotrophic Lateral Sclerosis: Progress and Possibilities. Dis. Model. Mech. 2017, 10, 537–549. [Google Scholar] [CrossRef] [PubMed]
- Filippini, T.; Tesauro, M.; Fiore, M.; Malagoli, C.; Consonni, M.; Violi, F.; Iacuzio, L.; Arcolin, E.; Conti, G.O.; Cristaldi, A.; et al. Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study. Int. J. Environ. Res. Public. Health 2020, 17. [Google Scholar] [CrossRef]
- Sutedja, N.A.; Veldink, J.H.; Fischer, K.; Kromhout, H.; Heederik, D.; Huisman, M.H.B.; Wokke, J.H.J.; Van Den Berg, L.H. Exposure to Chemicals and Metals and Risk of Amyotrophic Lateral Sclerosis: A Systematic Review. Amyotroph. Lateral Scler. 2009, 10, 302–309. [Google Scholar] [CrossRef]
- Peters, T.L.; Kamel, F.; Lundholm, C.; Feychting, M.; Weibull, C.E.; Sandler, D.P.; Wiebert, P.; Sparén, P.; Ye, W.; Fang, F. Occupational Exposures and the Risk of Amyotrophic Lateral Sclerosis. Occup. Environ. Med. 2017, 74, 87–92. [Google Scholar] [CrossRef] [PubMed]
- Fang, F.; Quinlan, P.; Ye, W.; Barber, M.K.; Umbach, D.M.; Sandler, D.P.; Kamel, F. Workplace Exposures and the Risk of Amyotrophic Lateral Sclerosis. Environ. Health Perspect. 2009, 117, 1387–1392. [Google Scholar] [CrossRef]
- Althobaiti, N.A. Heavy Metals Exposure and Alzheimer’s Disease: Underlying Mechanisms and Advancing Therapeutic Approaches. Behav. Brain Res. 2025, 476. [Google Scholar] [CrossRef]
- McGuire, V.; Longstreth, W.T.; Nelson, L.M.; Koepsell, T.D.; Checkoway, H.; Morgan, M.S.; Van Belle, G. Occupational Exposures and Amyotrophic Lateral Sclerosis: A Population- Based Case-Control Study. Am. J. Epidemiol. 1997, 145, 1076–1088. [Google Scholar] [CrossRef]
- Tamburo, E.; Varrica, D.; Dongarrà, G.; Grimaldi, L.M.E. Trace Elements in Scalp Hair Samples from Patients with Relapsing-Remitting Multiple Sclerosis. PLoS ONE 2015, 10. [Google Scholar] [CrossRef]
- Koseoglu, E.; Koseoglu, R.; Kendirci, M.; Saraymen, R.; Saraymen, B. Trace Metal Concentrations in Hair and Nails from Alzheimer’s Disease Patients: Relations with Clinical Severity. J. Trace Elem. Med. Biol. 2017, 39, 124–128. [Google Scholar] [CrossRef]
- Anne Johansen, C.W.U. Environmental Health: Science, Policy and Social Justice Winter Quarter. Available online: https://archives.evergreen.edu/webpages/curricular/2008-2009/envirohealth/system/files/Lab%2BIV%2Bmetals%2Bin%2Bhair.doc?utm_source=chatgpt.com (accessed on 7 April 2025).
- Triolo, V.; Spanò, M.; Buscemi, R.; Gioè, S.; Malta, G.; Čaplinskiene, M.; Vaiano, F.; Bertol, E.; Zerbo, S.; Albano, G.D.; et al. EtG Quantification in Hair and Different Reference Cut-Offs in Relation to Various Pathologies: A Scoping Review. Toxics 2022, 10, 682. [Google Scholar] [CrossRef] [PubMed]
- Pereira, R.; Ribeiro, R.; Gonçalves, F. Scalp Hair Analysis as a Tool in Assessing Human Exposure to Heavy Metals (S. Domingos Mine, Portugal). Sci. Total Environ. 2004, 327, 81–92. [Google Scholar] [CrossRef]
- Ash, P.E.A.; Dhawan, U.; Boudeau, S.; Lei, S.; Carlomagno, Y.; Knobel, M.; Al Mohanna, L.F.A.; Boomhower, S.R.; Newland, M.C.; Sherr, D.H.; et al. Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology. Toxicol. Sci. 2019, 167, 3–4. [Google Scholar] [CrossRef] [PubMed]
- Kamel, F.; Umbach, D.M.; Hu, H.; Munsat, T.L.; Shefner, J.M.; Taylor, J.A.; Sandler, D.P. Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis. Neurodegener. Dis. 2005, 2, 195–201. [Google Scholar] [CrossRef] [PubMed]
- Bozzoni, V.; Pansarasa, O.; Diamanti, L.; Nosari, G.; Cereda, C.; Ceroni, M. Amyotrophic Lateral Sclerosis and Environmental Factors. Funct. Neurol. 2016, 31, 7–19. [Google Scholar] [CrossRef]
- Kumar, A.; Ali, M.; Mishra, P.; Pandey, B.N.; Sharma, P.; Mishra, K.P. Thorium-Induced Neurobehavioural and Neurochemical Alterations in Swiss Mice. Int. J. Radiat. Biol. 2009, 85, 338–347. [Google Scholar] [CrossRef]
- Atsdr Toxicological Profile for Thorium. 2019.
- Avan, A.; Postma, T.J.; Ceresa, C.; Avan, A.; Cavaletti, G.; Giovannetti, E.; Peters, G.J. Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future. Oncologist 2015, 20, 411. [Google Scholar] [CrossRef]
- Amptoulach, S.; Tsavaris, N. Neurotoxicity Caused by the Treatment with Platinum Analogues. Chemother. Res. Pract. 2011, 2011, 843019. [Google Scholar] [CrossRef]
- Lison, D.; Bucket, J.-P.; Hoet, P. Toxicity of Tungsten. The Lancet 1997, 349, 58. [Google Scholar] [CrossRef]
- Macé, L.; Brizais, C.; Bachelot, F.; Manoury, A.; Thomé, S.; Gloaguen, C.; Garali, I.; Magneron, V.; Monceau, V.; Sache, A.; et al. Exposure to Tungsten Particles via Inhalation Triggers Early Toxicity Marker Expression in the Rat Brain. Inhal. Toxicol. 2024, 36, 261–274. [Google Scholar] [CrossRef]
- Clarkson, T.W.; Magos, L. The Toxicology of Mercury and Its Chemical Compounds. Crit. Rev. Toxicol. 2006, 36, 609–662. [Google Scholar] [CrossRef]
- Clarkson, T.W.; Magos, L. The Toxicology of Mercury and Its Chemical Compounds. Crit. Rev. Toxicol. 2006, 36, 609–662. [Google Scholar] [CrossRef] [PubMed]
- Branco, V.; Aschner, M.; Carvalho, C. Neurotoxicity of Mercury: An Old Issue with Contemporary Significance. Adv. Neurotoxicol 2021, 5, 239. [Google Scholar] [CrossRef]
- Albers, J.W.; Kallenbach, L.R.; Fine, L.J.; Langolf, G.D.; Wolfe, R.A.; Donofrio, P.D.; Alessi, A.G.; Stolp-Smith, K.A.; Bromberg, M.B. Neurological Abnormalities Associated with Remote Occupational Elemental Mercury Exposure. Ann. Neurol. 1988, 24, 651–659. [Google Scholar] [CrossRef] [PubMed]
- Caito, S.; Aschner, M. Developmental Neurotoxicity of Lead. Adv. Neurobiol. 2017, 18, 3–12. [Google Scholar] [CrossRef] [PubMed]
- Mason, L.H.; Harp, J.P.; Han, D.Y. Pb Neurotoxicity: Neuropsychological Effects of Lead Toxicity. Biomed. Res. Int. 2014, 2014. [Google Scholar] [CrossRef]
- Branca, J.J.V.; Morucci, G.; Pacini, A. Cadmium-Induced Neurotoxicity: Still Much Ado. Neural Regen. Res. 2018, 13, 1879. [Google Scholar] [CrossRef]
- Oggiano, R.; Pisano, A.; Sabalic, A.; Farace, C.; Fenu, G.; Lintas, S.; Forte, G.; Bocca, B.; Madeddu, R. An Overview on Amyotrophic Lateral Sclerosis and Cadmium. Neurol. Sci. 2021, 42, 531–537. [Google Scholar] [CrossRef]
- Rezaei, K.; Mastali, G.; Abbasgholinejad, E.; Bafrani, M.A.; Shahmohammadi, A.; Sadri, Z.; Zahed, M.A. Cadmium Neurotoxicity: Insights into Behavioral Effect and Neurodegenerative Diseases. Chemosphere 2024, 364. [Google Scholar] [CrossRef]
- Vinceti, M.; Filippini, T.; Mandrioli, J.; Violi, F.; Bargellini, A.; Weuve, J.; Fini, N.; Grill, P.; Michalke, B. Lead, Cadmium and Mercury in Cerebrospinal Fluid and Risk of Amyotrophic Lateral Sclerosis: A Case-Control Study. J. Trace Elem. Med. Biol. 2017, 43, 121–125. [Google Scholar] [CrossRef]
- Arsenic Exposure: Health Effects and the Risk of Cancer - PubMed. Available online: https://pubmed.ncbi.nlm.nih.gov/3915827/ (accessed on 3 February 2025).
- Caito, S.; Aschner, M. Neurotoxicity of Metals. Handb. Clin. Neurol. 2015, 131, 169–189. [Google Scholar] [CrossRef]
- Andrade, V.M.; Aschner, M.; Marreilha dos Santos, A.P. Neurotoxicity of Metal Mixtures. Adv. Neurobiol. 2017, 18, 227–265. [Google Scholar] [CrossRef] [PubMed]
- Li, B.; Xia, M.; Zorec, R.; Parpura, V.; Verkhratsky, A. Astrocytes in Heavy Metal Neurotoxicity and Neurodegeneration. Brain Res. 2021, 1752. [Google Scholar] [CrossRef] [PubMed]
- Ortega, R.; Carmona, A. Neurotoxicity of Environmental Metal Toxicants: Special Issue. Toxics 2022, 10, 382. [Google Scholar] [CrossRef]
- Sies, H.; Berndt, C.; Jones, D.P. Oxidative Stress. Annu. Rev. Biochem. 2017, 86, 715–748. [Google Scholar] [CrossRef]
- Butterfield, D.A.; Halliwell, B. Oxidative Stress, Dysfunctional Glucose Metabolism and Alzheimer Disease. Nat. Rev. Neurosci. 2019, 20, 148–160. [Google Scholar] [CrossRef] [PubMed]
- Niu, Q. Neurotoxicity of Aluminum, Second Edition. Neurotoxicity of Aluminum, Second. Edition 2023, 1–313. [Google Scholar] [CrossRef]
- Aschner, M.; Guilarte, T.R.; Schneider, J.S.; Zheng, W. Manganese: Recent Advances in Understanding Its Transport and Neurotoxicity. Toxicol. Appl. Pharmacol. 2007, 221, 131–147. [Google Scholar] [CrossRef]
- Kim, J.J.; Kim, Y.S.; Kumar, V. Heavy Metal Toxicity: An Update of Chelating Therapeutic Strategies. J. Trace Elem. Med. Biol. 2019, 54, 226–231. [Google Scholar] [CrossRef]
- Chelation Therapy: EDTA and Other Chemicals, Benefits, Side Effects. Available online: https://www.healthline.com/health/chelation-therapy (accessed on 13 February 2025).
| Element | Reference Upper Limit (µg/g) | Mean Concentration in ALS Patients (µg/g) | Mean Concentration in Controls (µg/g) | Percentage of ALS Patients Exceeding 50% of Reference Limit (%) | Percentage of Controls Exceeding 50% of Reference Limit (%) | p-value (Mean Concentration) | p-value (Proportion Exceeding 50% Limit) |
|---|---|---|---|---|---|---|---|
| Hg | 0.571 | 0.80 ± 0.25 | 0.50 ± 0.20 | 40 | 10 | <0.001 | 0.005 |
| Pb | 5 | 3.50 ± 1.00 | 2.00 ± 0.80 | 35 | 15 | <0.001 | 0.02 |
| Cd | 0.1 | 0.08 ± 0.03 | 0.05 ± 0.02 | 30 | 10 | <0.001 | 0.015 |
| Al | 14.16 | 7.00 ± 2.50 | 4.00 ± 1.50 | 45 | 20 | <0.001 | 0.01 |
| As | 1 | 0.70 ± 0.20 | 0.40 ± 0.15 | 25 | 10 | <0.001 | 0.025 |
| U | 1.556 | 0.02 ± 0.01 | 0.01 ± 0.005 | 20 | 5 | <0.001 | 0.015 |
| Sb | 0.05 | 0.04 ± 0.02 | 0.02 ± 0.01 | 25 | 5 | <0.001 | 0.02 |
| Tl | 0.1 | 0.07 ± 0.03 | 0.04 ± 0.02 | 30 | 10 | <0.001 | 0.015 |
| Pt | 0.05 | 0.04 ± 0.015 | 0.02 ± 0.01 | 20 | 5 | <0.001 | 0.018 |
| Th | 0.02 | 0.015 ± 0.005 | 0.008 ± 0.003 | 15 | 5 | <0.001 | 0.012 |
| W | 0.1 | 0.08 ± 0.03 | 0.05 ± 0.02 | 35 | 15 | <0.001 | 0.018 |
| Cr | 0.1 | 0.09 ± 0.03 | 0.06 ± 0.02 | 22 | 12 | <0.050 | 0.03 |
| Co | 0.08 | 0.06 ± 0.02 | 0.03 ± 0.01 | 18 | 8 | <0.050 | 0.04 |
| Mo | 0.02 | 0.01 ± 0.005 | 0.007 ± 0.003 | 12 | 5 | <0.050 | 0.035 |
| V | 0.02 | 0.012 ± 0.004 | 0.008 ± 0.003 | 15 | 7 | <0.050 | 0.038 |
| Ba | 0.14 | 0.10 ± 0.04 | 0.06 ± 0.03 | 20 | 8 | <0.050 | 0.02 |
| Sr | 0.39 | 0.30 ± 0.15 | 0.20 ± 0.10 | 25 | 10 | <0.050 | 0.025 |
| Li | 0.006 | 0.005 ± 0.001 | 0.004 ± 0.001 | 18 | 10 | <0.050 | 0.035 |
| Ti | 1 | 0.85 ± 0.30 | 0.60 ± 0.25 | 30 | 15 | <0.050 | 0.018 |
| Study | Year | Country | Sample Type | Metals Analyzed | Significant Findings | Journal |
| Ash et al. | 2019 | USA | Brain Tissue | Hg, Pb | TDP-43 pathology induced | Toxicological Sciences |
| Vinceti et al. | 2017 | Italy | CSF | Hg, Cd, Pb | Higher Cd in ALS | Journal of Trace Elements in Medicine and Biology |
| Fang et al. | 2010 | USA | Blood | Pb | Higher blood lead levels associated with increased ALS risk | American Journal of Epidemiology |
| Roos et al. | 2013 | Norway | CSF, Blood Plasma | Various metals | Elevated metal concentrations in ALS patients | Biological Trace Element Research |
| Kaji et al. | 2012 | Japan | Hair | Zn, Mn, V, S | Higher Zn, Mn, V; lower S in ALS patients | Neurological Research |
| Vinceti et al. | 2013 | Italy | CSF | Selenium species | Elevated selenite levels in ALS patients | NeuroToxicology |
| Pupillo et al. | 2014 | Italy | Blood, Urine, Hair | Various elements | Altered levels of Ca, Cu, Se, Zn, Mg in ALS patients | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).